An underground market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and chemists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could result in individuals administering products of uncertain source.
Several professionals said the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, marketing, and customer regulations, risking fines, prosecution or prison.
Platform Reaction and Content Elimination
Based on TikTok, the platform has removed problematic material and prohibited related keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.
Online Marketplace Operations
Research also found communities with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.
Within minutes of entering one community, a seller shared WhatsApp details, where most transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, health issues or past usage.
Product Details and Pricing
Inside these communities, messages show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has already seen individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially serious medical dangers”.
